Skip to content
Acting Auditions – Lifestyle
Author:
Inimmune Corporation
Inimmune Presents Late-Breaking Phase 1 INI-4001 Results Demonstrating On-Target Immune Activation in Advanced Solid Tumors at SITC 2026
November 6, 2026